Efficacy of teriparatide in patients with hypoparathyroidism: A prospective, open-label study
Context: Conventional treatment of hypoparathyroidism with calcium, Vitamin D analogs, and thiazide diuretics is often suboptimal, and these patients have poor quality of life. Teriparatide (parathyroid hormone 1–34 [PTH (1–34)]), an amide of PTH, is widely available for the use in osteoporosis; how...
Main Authors: | Vimal Upreti, Shrikant Somani, Narendra Kotwal |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2017-01-01
|
Series: | Indian Journal of Endocrinology and Metabolism |
Subjects: | |
Online Access: | http://www.ijem.in/article.asp?issn=2230-8210;year=2017;volume=21;issue=3;spage=415;epage=418;aulast=Upreti |
Similar Items
-
A registry for patients with chronic hypoparathyroidism in Russian adults
by: Sofya Gronskaia, et al.
Published: (2020-07-01) -
Hypoparathyroidism: disease update and new methods of treatment
by: Tatiana A. Grebennikova, et al.
Published: (2017-09-01) -
Treatment of severe idiopathic hypoparathyroidism: a case report
by: Diliara Sh. Umiarova, et al.
Published: (2018-12-01) -
EXPERIENCE OF LONG-TERM TERIPARATIDE USE FOR THE TREATMENT OF POSTOPERATIVE HYPOPARATHYROIDISM ASSOCIATED WITH OSTEOPOROSIS IN ELDERLY PATIENT
by: G. A. Batrak, et al.
Published: (2018-11-01) -
Teriparatide Treatment in Patients with Severe Osteoporosis: Effects on Bone Mineral Density, Biochemical Parameters, Back Pain and Quality of Life
by: Alev Çevikol, et al.
Published: (2014-08-01)